Skip to main content
. 2022 Jun 18;10(6):1441. doi: 10.3390/biomedicines10061441

Figure 4.

Figure 4

Targeted OV delivery to cancer cells. This illustration highlights a non-exhaustive list of the delivery platforms that have been reported in the literature to protect OVs from neutralizing antibodies as well as enhance targeted delivery by external or internal stimuli. Many are carriers but also facilitators and may be either organic or inorganic in nature. Adapted from “Nanoparticle-Mediated Targeted Drug Delivery to Cancer Stem Cells”, by BioRender.com (2022) (accessed on 28 March 2022). Retrieved from https://app.biorender.com/biorender-templates (accessed on 28 March 2022).